On Monday, the Food and Drug Administration approved the country’s first drug derived from marijuana.
The drug, GW Pharmaceuticals’ Epidiolex, treats two different forms of epilepsy, according to StatNews. Consisting of cannabidiol (CBD), which doesn’t elicit a high among users, it will be sold as an oil, and demonstrated its success in trails where it reduced seizures by 40% in patients with Dravet or Lennox-Gastaut syndromes.
.png)
.png)

